Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma

This publication has 20 references indexed in Scilit:

• Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
  Annals of Oncology, 2001
• Investigation of monoclonal antibody therapy with conventional and high-dose treatment: Current clinical trials
  Seminars in Hematology, 2000
• Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
  Blood, 1999
• Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
  Journal of Clinical Oncology, 1999
• Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.
  Journal of Clinical Oncology, 1998
• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
  Journal of Clinical Oncology, 1998
• BCL-2 FAMILY: Regulators of Cell Death
  Annual Review of Immunology, 1998
• Purging Peripheral Blood Progenitor Cell Grafts from Lymphoma Cells: Quantitative Comparison of Immunomagnetic CD34 ⁺ Selection Systems
  The International Journal of Cell Cloning, 1997
• BCL2 translocation frequency rises with age in humans.
  Proceedings of the National Academy of Sciences, 1994
• The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas
  New England Journal of Medicine, 1984